Caspase-1 substrate
Fluorogenic caspase-1 substrate with a Km=14µM. Ex.:340-360nm, Em.:440-460nm.Sequence is based on precursor interleukin-1β Asp116 cleavage site for caspase-1.
Shipping: Available products typically ship within 24/48h, via priority shipping.
Do you need support? Contact Customer Service or Technical Support.
Online Account
Access or Create Your Account
Product Details
Alternative Name |
Caspase-1 substrate (fluorogenic) |
---|---|
Appearance |
White to off-white powder. |
Formula |
C33H39N5O10 |
MW |
665.7 |
Peptide Content |
75-95% |
Purity |
≥98% (HPLC) |
Sequence |
Ac-Tyr-Val-Ala-Asp-AMC (AMC = 7-Amino-4-methylcoumarin) |
Solubility |
Soluble in DMSO. Dilute with distilled water or buffer, pH 7.0-7.5 (e. g. TRIS, HEPES). |
Technical Info / Product Notes |
AMC has an excitation maximum of 340-360nm and an emission maximum of 440-460nm. |
Handling & Storage
Use/Stability |
As indicated on product label or CoA when stored as recommended. |
---|---|
Handling |
Protect from light. Keep cool and dry. |
Long Term Storage |
-20°C |
Shipping |
Ambient Temperature |
Regulatory Status |
RUO – Research Use Only |
---|
- Cardioprotective properties of OMT-28, a synthetic analog of omega-3 epoxyeicosanoids: Kranrod, J., Konkel, A., et al.; J. Biol. Chem. 300, 107372 (2024), Abstract
- Cardioprotective Action of a Novel Synthetic 19,20-EDP Analog Is Sirt Dependent: Kranrod, J. W., Darwesh, A. M., et al.; J. Cardiovasc. Pharmacol. 83, 105 (2024), Abstract
- Characterization of heart disease in mucopolysaccharidosis type II mice: A.M.V. Tavares, et al.; Cardiovasc. Pathol. 67, 107575 (2023), Abstract
- Trimethylamine N-Oxide (TMAO) Mediates Increased Inflammation and Colonization of Bladder Epithelial Cells during a Uropathogenic E. coli Infection In Vitro: R. Wu, et al.; Pathogens 12, 523 (2023), Abstract
- Neutrophil membrane-coated nanoparticles exhibit increased antimicrobial activities in an anti-microbial resistant K. pneumonia infection model: J. Liu, et al.; Nanomedicine 48, 102640 (2023), Abstract
- Cardioprotective Effects of Oroxylum indicum Extract Against Doxorubicin and Cyclophosphamide-Induced Cardiotoxicity: S.R. Pondugula, et al.; Cardiovasc. Toxicol. 22, 67 (2022), Abstract
- Cardiomyocyte-specific disruption of soluble epoxide hydrolase limits inflammation to preserve cardiac function: Sosnowski, D. K., Jamieson, K. L., et al.; Am. J. Physiol. Heart Circ. Physiol. 323, H670 (2022), Abstract
- The structure of the human LACTB filament reveals the mechanisms of assembly and membrane binding: J.A. Bennett, et al.; PLoS Biol. 20, e3001899 (2022), Abstract
- β-hydroxybutyric acid attenuates oxidative stress and improves markers of mitochondrial function in the HT-22 hippocampal cell line: M. Majrashi, et al.; J. Integr. Neurosci. 20, 321 (2021), Abstract
- A Synthetic Epoxydocosapentaenoic Acid Analogue Ameliorates Cardiac Ischemia/Reperfusion Injury: The Involvement of the Sirtuin 3-NLRP3 Pathway: Darwesh, A. M., Bassiouni, W., et al.; Int. J. Mol. Sci. 21, (2020), Abstract
- Niclosamide activates the NLRP3 inflammasome by intracellular acidification and mitochondrial inhibition: Thi Tran, U., Kitami, T., et al.; Commun. Biol. 2, 2 (2019), Abstract
- Genetic Deletion or Pharmacological Inhibition of Soluble Epoxide Hydrolase Ameliorates Cardiac Ischemia/Reperfusion Injury by Attenuating NLRP3 Inflammasome Activation: Darwesh, A. M., Keshavarz-Bahaghighat, H., et al.; Int. J. Mol. Sci. 20, (2019), Abstract
- Clearance of intracellular Klebsiella pneumoniae infection using gentamicin-loaded nanoparticles: L. Jiang, et al.; J. Control Release 279, 316 (2018), Abstract
- Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism: J.V. Raleigh, et al.; Cardiovasc Res 113, 609 (2017), Application(s): Caspase-1 activity in mouse heart homogenates, Abstract
- Design and application of a fluorogenic assay for monitoring inflammatory caspase activity: R. Ranganathan, et al.; Anal. Biochem. 543, 1 (2017), Abstract
- Temporal Changes in Caspase-1 and Caspase-8 Activities Following Brain Hypoxia With and Without Src kinase Inhibition in a Piglet Animal Model: D. Angelis, et al.; Neurochem. Res. 40, 2270 (2015), Abstract
- Interleukin-1 β converting enzyme: N.A. Thornberry; Meth. Enzymol. 244, 615 (1994), Abstract
- Crystal structure of the cysteine protease interleukin-1 β-converting enzyme: a (p20/p10)2 homodimer: N.P.C. Walker, et al.; Cell 78, 343 (1994), Abstract
- Interleukin 1 beta (IL-1 beta) processing in murine macrophages requires a structurally conserved homologue of human IL-1 beta converting enzyme: S.M. Molineaux, et al.; PNAS 90, 1809 (1993), Abstract
- Molecular cloning of the interleukin-1 beta converting enzyme: D.P. Cerretti, et al.; Science 256, 97 (1992), Abstract
- A novel heterodimeric cysteine protease is required for interleukin-1 β processing in monocytes: N.A. Thornberry, et al.; Nature 356, 768 (1992), Abstract
- IL-1-converting enzyme requires aspartic acid residues for processing of the IL-1 beta precursor at two distinct sites and does not cleave 31-kDa IL-1 alpha: A.D. Howard, et al.; J. Immunol. 147, 2964 (1991), Abstract
Datasheet, Manuals, SDS & CofA
Manuals And Inserts
Certificate of Analysis
Please enter the lot number as featured on the product label
SDS
Enzo Life Science provides GHS Compliant SDS
If your language is not available please fill out the SDS request form